Apply to be an ATS Fellow!
On June 1, the ATS began accepting applications for its second class of ATS Fellows, open to individuals who have been an ATS member for five or more years. With recognition at the ATS International Conference, on the ATS website, and in member publications, the ATS Fellow designation is a mark of distinction, honoring members for their accomplishments, dedication, and contributions to the Society, as well as to the fields of pulmonary, critical care, and sleep medicine. For questions, refer to the ATS Fellow FAQs. Apply now.
Now Available: ATS Review for Critical Care Medicine Board
Designed for fellows-in-training and practicing physicians, the ATS Review for the Critical Care Boards will help you prepare to take the American Board of Internal Medicine (ABIM) Critical Care Medicine Certification exam, scheduled for Nov. 12, 2018.
ATS members save 20 percent on the ATS Review book!
Please email education@thoracic.org, or contact ATS Education Coordinator Odalys Jimenez at 212-315-8608 with any questions.
Lung Disease Week at ATS: Scleroderma
From June 3 to June 9, the ATS will highlight scleroderma as part of its Lung Disease Week series. Scleroderma is a progressive autoimmune disease that affects the skin and connective tissue, including cartilage, bone, fat, and the tissue that supports the nerves and blood vessels throughout the body.
There are two major forms of the disorder: localized scleroderma, which mainly affects the skin, and systemic scleroderma, which may also affect the internal organs of the body, including the lungs. There is no cure for scleroderma, but there are a number of FDA-approved treatment options for the associated pulmonary arterial hypertension.
In conjunction with the Scleroderma Foundation, the ATS hosted a live webinar, "Lung in Scleroderma.” The webinar was presented by Virginia Steen, MD, of Georgetown University, and will be available on the ATS website.
ATS Foundation Research Program and American Lung Association in Oregon Award Partner Grant to Matthew G. Drake, MD
The American Thoracic Society Foundation Research Program and the American Lung Association in Oregon have awarded a $100,000 ATS Foundation Partner Grant to Matthew G. Drake, MD, of Oregon Health and Science University.
Dr. Drake’s research examines “Sensory Nerve Plasticity and P2X Receptor Expression in Chronic Cough,” in which he hypothesizes that eosinophils stimulate airway sensory nerve growth and neuronal P2X3 expression, which leads to increased asthma symptoms.
Since it began in 2004, the ATS Foundation Research Program has awarded $17.6 million to 235 investigators, both in the U.S. and internationally. These researchers have gone on to receive $268 million in federal funding. That’s a return on investment of $15 per dollar awarded. See all of the ATS Foundation Research Program Partner Grant recipients for the 2017 grant cycle.
Evaluation of the 2018 ATS International Conference
Thank you for attending the ATS 2018 International Conference. The ATS is one of the few associations to have an independent-third-party perform an attendee audit of our conference. The attendee audit validates the conference registration numbers to ensure we are reporting accurate information.
The attendee audit is performed by Exhibit Surveys, Inc. You may receive an email or a telephone call from Exhibit Surveys, Inc. starting on June 12th to verify your attendance at the conference. The verification consists of a few quick questions which may include some of the demographic data you provided via the registration process. This is done to ensure accuracy of the information.
If you receive the email or telephone call from Exhibit Surveys, Inc., we would greatly appreciate it if you would take a few minutes to answer their questions.
Thank you for your participation in the audit.
